Skip to main content

REGIS CORP

For the period ended Jun 30, 2024. Filed Aug 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Aug 28, 2024

RGS$24.07+0.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

REGIS CORPORATION
By/s/ MATTHEW DOCTOR
Matthew Doctor,President and Chief Executive Officer(Principal Executive Officer)
By/s/ KERSTEN D. ZUPFER
Kersten D. Zupfer,Executive Vice President and Chief Financial Officer(Principal Financial and Accounting Officer)
Date: August 28, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

/s/ DAVID J. GRISSEN
David J. Grissen, Chairman of the Board of DirectorsDate: August 28, 2024
/s/ LOCKIE ANDREWS
Lockie Andrews, DirectorDate: August 28, 2024
/s/ NANCY BENACCI
Nancy Benacci, DirectorDate: August 28, 2024
/s/ MATTHEW DOCTOR
Matthew Doctor,DirectorDate: August 28, 2024
/s/ MARK LIGHT
Mark Light, DirectorDate: August 28, 2024
/s/ MICHAEL MANSBACH
Michael Mansbach,DirectorDate: August 28, 2024
/s/ MICHAEL J. MERRIMAN
Michael J. Merriman, DirectorDate: August 28, 2024
/s/ M. ANN RHOADES
M. Ann Rhoades, DirectorDate: August 28, 2024
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.